[go: up one dir, main page]

MX2018011162A - Metodos de purificacion de colageno 7. - Google Patents

Metodos de purificacion de colageno 7.

Info

Publication number
MX2018011162A
MX2018011162A MX2018011162A MX2018011162A MX2018011162A MX 2018011162 A MX2018011162 A MX 2018011162A MX 2018011162 A MX2018011162 A MX 2018011162A MX 2018011162 A MX2018011162 A MX 2018011162A MX 2018011162 A MX2018011162 A MX 2018011162A
Authority
MX
Mexico
Prior art keywords
methods
recombinant collagen
purifying collagen
purifying
collagen
Prior art date
Application number
MX2018011162A
Other languages
English (en)
Inventor
Nichols David
Yang Ting
Quiñones Garcia Igor
Simeone Benjamin
Lillie Raymond
Original Assignee
Phoenix Tissue Repair Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phoenix Tissue Repair Inc filed Critical Phoenix Tissue Repair Inc
Publication of MX2018011162A publication Critical patent/MX2018011162A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente divulgacion proporciona metodos para capturar el colageno 7 recombinante del cultivo celular y metodos para purificar el colageno 7 recombinante. Tambien se proporcionan composiciones que comprenden colageno 7 recombinante purificado que puede usarse para administracion a humanos.
MX2018011162A 2016-03-16 2017-03-10 Metodos de purificacion de colageno 7. MX2018011162A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662309030P 2016-03-16 2016-03-16
PCT/US2017/021815 WO2017160636A1 (en) 2016-03-16 2017-03-10 Methods of purifying collagen 7

Publications (1)

Publication Number Publication Date
MX2018011162A true MX2018011162A (es) 2018-11-22

Family

ID=59852081

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018011162A MX2018011162A (es) 2016-03-16 2017-03-10 Metodos de purificacion de colageno 7.

Country Status (7)

Country Link
US (1) US10669327B2 (es)
EP (1) EP3429615A4 (es)
JP (2) JP6985282B2 (es)
CN (1) CN109069592B (es)
CA (1) CA3015685A1 (es)
MX (1) MX2018011162A (es)
WO (1) WO2017160636A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX383947B (es) * 2015-12-23 2025-03-14 Phoenix Tissue Repair Inc Composiciones de colágeno 7 y métodos para usar las mismas.
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
US10792618B2 (en) * 2018-06-19 2020-10-06 Sartorius Stedim Biotech Gmbh Particle separation and/or purification of a fluid
SG11202111349QA (en) 2019-04-12 2021-11-29 Geltor Inc Recombinant elastin and production thereof
WO2021101899A1 (en) * 2019-11-20 2021-05-27 Nxstage Medical, Inc. Methods, devices, and systems for providing peritoneal dialysis fluid from powdered concentrate
CN113121638B (zh) * 2020-01-15 2022-06-14 鲁南制药集团股份有限公司 一种纯化重组蛋白的方法
MX2022009036A (es) 2020-01-24 2022-11-14 Geltor Inc Colageno dietetico no de animales.
US11504716B2 (en) * 2020-06-05 2022-11-22 Pall Corporation Multiwell device and method of use
JP2023548655A (ja) * 2020-10-08 2023-11-20 ジェラテック インコーポレイテッド 動物細胞株および／または組織外植片からのコラーゲンおよび／またはゼラチンの産生、単離および／または抽出
KR20240004264A (ko) * 2021-03-04 2024-01-11 젤라텍, 인크. 배양된 동물 세포로부터의 콜라겐을 사용한 재료의 제조 방법
CN114805548B (zh) * 2021-12-29 2023-11-14 江苏创健医疗科技股份有限公司 一种重组胶原蛋白冻干纤维及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO599897A0 (en) * 1997-04-03 1997-05-01 Vidal, Linus Clear collagen for facial implants
AU2006292739A1 (en) * 2005-09-15 2007-03-29 Wyeth Protein floculation using salts
US9040484B2 (en) * 2011-04-26 2015-05-26 The Board Of Trustees Of The Leland Stanford Junior University Production and delivery of a stable collagen
AU2012289916B2 (en) * 2011-08-03 2017-08-03 Phoenix Tissue Repair, Inc. Collagen 7 and related methods
US9067990B2 (en) * 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9334319B2 (en) * 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
US20140031295A1 (en) * 2012-07-19 2014-01-30 Lotus Tissue Repair, Inc. Recombinant C7 and Methods of Use
EA030551B1 (ru) * 2013-01-09 2018-08-31 Шир Хьюман Дженетик Терапис, Инк. Способы очистки арилсульфатазы а
WO2015042639A1 (en) * 2013-09-24 2015-04-02 Hospira Adelaide Pty Ltd Method of extracting protein

Also Published As

Publication number Publication date
JP7340583B2 (ja) 2023-09-07
JP2022016605A (ja) 2022-01-21
WO2017160636A1 (en) 2017-09-21
US20190077845A1 (en) 2019-03-14
EP3429615A1 (en) 2019-01-23
JP2019511498A (ja) 2019-04-25
CN109069592B (zh) 2023-03-07
CA3015685A1 (en) 2017-09-21
US10669327B2 (en) 2020-06-02
EP3429615A4 (en) 2019-11-06
CN109069592A (zh) 2018-12-21
JP6985282B2 (ja) 2021-12-22

Similar Documents

Publication Publication Date Title
MX2018011162A (es) Metodos de purificacion de colageno 7.
PH12020500500A1 (en) Pyrazolopyrimidinone compounds and uses thereof
EP4620521A3 (en) Methods and compositions relating to chondrisomes from cultured cells
MX389228B (es) Composiciones para tratar el cabello.
MX2021001186A (es) Purinonas como inhibidores de proteasa especifica de ubiquitina 1.
EP4516319A3 (en) Subcutaneous formulations of anti-cd38 antibodies and their uses
MX2020014031A (es) Proteinas heterodimericas y usos de las mismas.
SG10201811454WA (en) Materials and methods for controlling infections
MX2015011898A (es) Compuestos de pirazolo y usos de los mismos.
SG10201902872YA (en) Ex vivo proliferation of epithelial cells
MX2022014532A (es) Metodo para seleccionar proteinas recombinantes ricas en m6p.
MX2017001971A (es) Composiciones antimetanogenicas y sus usos.
PH12018500379B1 (en) Biopharmaceutical compositions
MY193650A (en) Extracellular matrix compositions
MY190647A (en) Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof
PH12019502036A1 (en) Peptides and methods for the treatment of diabetes
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
EA201990998A1 (ru) Фармацевтические составы и способы их получения
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
WO2017093810A3 (en) Composition for intraoral delivery of biologically active peptides and proteins
SG10201805890QA (en) Compositions and methods for treatment of abnormal cell growth
AU2015267160A8 (en) Methods and compositions for preventing ischemia reperfusion injury in organs
MX2020002552A (es) Métodos y composiciones para preparar proteína surfactante d (sp-d).
WO2018119312A8 (en) Methods and formulations for reducing reconstitution time of lyophilized polypeptides
MY193996A (en) Tripeptide compound, preparation method therefor, and application thereof